AI Biomed PredictionsZNTL – ASCO follow-through could spark Zentalis’ next ovarian cancer rerating ScanScor Admin / May 31, 2026
AI Biomed PredictionsALLR – ALLR’s next rerating likely hinges on ovarian enrollment completion ScanScor Admin / April 21, 2026
